A New TGF-β1 Inhibitor, CTI-82, Antagonizes Epithelial-Mesenchymal Transition through Inhibition of Phospho-SMAD2/3 and Phospho-ERK

Autor: Younghwa Na, Ji-Hye Song, Gi-Jun Sung, Hayeon Park, Kyung-Chul Choi, Minseok Jeong, Ji-Hoon Jeong, Sungmin Kwak, Hyunhee Kim, Seung-Ho Park
Rok vydání: 2020
Předmět:
Zdroj: Biology
Biology, Vol 9, Iss 143, p 143 (2020)
Volume 9
Issue 7
ISSN: 2079-7737
Popis: Transforming growth factor-&beta
1 (TGF-&beta
1) is highly expressed in the tumor microenvironment and known to play a multifunctional role in cancer progression. In addition, TGF-&beta
1 promotes metastasis by inducing epithelial&ndash
mesenchymal transition (EMT) in a variety of tumors. Thus, inhibition of TGF-&beta
1 is considered an important strategy in the treatment of cancer. In most tumors, TGF-&beta
1 signal transduction exhibits modified or non-functional characteristics, and TGF-&beta
1 inhibitors have various inhibitory effects on cancer cells. Currently, many studies are being conducted to develop TGF-&beta
1 inhibitors from non-toxic natural compounds. We aimed to develop a new TGF-&beta
1 inhibitor to suppress EMT in cancer cells. As a result, improved chalcone-like chain CTI-82 was identified, and its effect was confirmed in vitro. We showed that CTI-82 blocked TGF-&beta
1-induced EMT by inhibiting the cell migration and metastasis of A549 lung cancer cells. In addition, CTI-82 reduced the TGF-&beta
1-induced phosphorylation of SMAD2/3 and inhibited the expression of various EMT markers. Our results suggest that CTI-82 inhibits tumor growth, migration, and metastasis.
Databáze: OpenAIRE